The November 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 16, Issue 4
Editorial
For success in biotechnology, look beyond biotechnology | |
Yali Friedman |
Commentary
Federal bureaucrats slip on oil spill | |
Henry I Miller |
Articles
R&D spending and sources of funding of private US biopharmaceutical firms seeking to go public | |
David R Williams, Richard W Pouder |
Algae and Biodiesel: Patenting energized as green goes commercial | |
Matthew R Preiss, Stanley P Kowalski |
Biotechnology industry-physician interaction and OIG guidelines: Evidence from the stock market | |
Thani Jambulingam, WaQar Ghani, Rajneesh Sharma |
Exploratory assessment of the current EU regulatory framework for development of advanced therapies | |
Pawanbir Singh, Laure Brévignon-Dodin, Satya P Dash |
Patenting of microorganisms: Systems and concerns | |
Ramkumar Balachandra Nair, Pratap Chandran Ramachandranna |
Legal and Regulatory Updates
Legal and Regulatory Update | |
Gerry Kamstra |
The aftermath of Bilski | |
Thomas C Meyers, Adam M Schoen |
Commentary regarding decision in Bilski from a biotech perspective | |
Thomas J Kowalski, Heidi E Lunasin, Deborah L Lu, Brian M McGuire, Frank J DeRosa |
Book Reviews
Book Review: Biodesign: The process of innovating medical technologies | |
Randall Tagg, Catalina Bravo |